Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 April 2008, Vol. 111, No. 8, pp. 4055-4063.
Prepublished online as a Blood First Edition Paper on November 9, 2007; DOI 10.1182/blood-2007-05-091710.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-05-091710v1
111/8/4055    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Jokubaitis, V. J.
Right arrow Articles by Simmons, P. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jokubaitis, V. J.
Right arrow Articles by Simmons, P. J.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrowRelated Article in Blood Online
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMATOPOIESIS AND STEM CELLS

Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues

Vanta J. Jokubaitis1,2, Lidia Sinka3,4, Rebecca Driessen1, Genevieve Whitty5, David N. Haylock5, Ivan Bertoncello5, Ian Smith6, Bruno Péault7, Manuela Tavian3,4, and Paul J. Simmons1,8

1 Stem Cell Biology Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Australia; 2 Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Australia; 3 Inserm U602, Villejuif, France; 4 Universite Paris-Sud, Faculte de Medecine, Villejuif, France; 5 Australian Stem Cell Centre, Clayton, Australia; 6 Baker Institute, Prahran, Australia; 7 Rangos Research Center, Children's Hospital, Pittsburgh, PA; and 8 Brown Foundation Institute of Molecular Medicine (IMM), University of Texas Health Science Center, Houston, TX

Previous studies revealed that mAb BB9 reacts with a subset of CD34+ human BM cells with hematopoietic stem cell (HSC) characteristics. Here we map BB9 expression throughout hematopoietic development and show that the earliest definitive HSCs that arise at the ventral wall of the aorta and surrounding endothelial cells are BB9+. Thereafter, BB9 is expressed by primitive hematopoietic cells in fetal liver and in umbilical cord blood (UCB). BB9+CD34+ UCB cells transplanted into nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice contribute 10-fold higher numbers of multilineage blood cells than their CD34+BB9– counterparts and contain a significantly higher incidence of SCID-repopulating cells than the unfractionated CD34+ population. Protein microsequencing of the 160-kDa band corresponding to the BB9 protein established its identity as that of somatic angiotensin-converting enzyme (ACE). Although the role of ACE on human HSCs remains to be determined, these studies designate ACE as a hitherto unrecognized marker of human HSCs throughout hematopoietic ontogeny and adulthood.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

BB9 ACEs the HSC compartment
Mervin C. Yoder
Blood 2008 111: 3912. [Full Text] [PDF]





click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020